Lung wash test could unlock secrets of scarring lung diseases
NCT ID NCT07208201
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will use a procedure called bronchoalveolar lavage (BAL) to collect fluid from the lungs of 66 adults with suspected interstitial lung disease (ILD). The fluid will be analyzed to identify specific inflammatory cells, which may help doctors distinguish between different ILD types. The goal is to improve diagnosis and understanding of these lung conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve how doctors diagnose and manage interstitial lung diseases by using BAL fluid analysis.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct patient benefits, and results may not apply to all ILD patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a JAK inhibitor halt rapid lung decline?
- Could a vibrating platform help people with stiff lungs breathe easier?
- Massive study tracks lung disease progression in 4,000 patients
- New pill aims to halt lung scarring in thousands
- Massive 10-Year study aims to unlock secrets of rare lung disease
- Could a cancer drug slow lung scarring? new trial tests anlotinib for IPF